SCHEMBL3465758

SCHEMBL3465758

Fc1cccc(Cl)c1C=C(CBr)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
HPGD P15428 3/20 0.40
ALOX12 P18054 1/20 0.40
ATM Q13315 1/20 0.40
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 2/20 0.40
KMT2A Q03164 3/20 0.40
MAPT P10636 2/20 0.40
MDM4 O15151 1/20 0.40
MDM2 Q00987 1/20 0.40
RAB9A P51151 4/20 0.39
NPC1 O15118 3/20 0.39
HTT P42858 2/20 0.39
GAA P10253 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
PBRM1 Q86U86 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3465756 1.00 LMNA (0.40) LMNASMN1; SMN2HPGDALOX12ATM
SCHEMBL3465715 0.90 LMNA (0.43) LMNASMN1; SMN2HPGDALOX12ATM
SCHEMBL3465718 0.90 LMNA (0.43) LMNASMN1; SMN2HPGDALOX12ATM
SCHEMBL9669401 0.76 TRPA1 (0.44) LMNAHPGDALDH1A1KMT2AMAPT
SCHEMBL9669407 0.76 TRPA1 (0.44) LMNAHPGDALDH1A1KMT2AMAPT
SCHEMBL28495822 0.72 HDAC1 (0.47) SMN1; SMN2ALDH1A1KMT2ATDP1MEN1
SCHEMBL24075453 0.72 LMNA (0.47) LMNASMN1; SMN2HPGDALOX12ATM
SCHEMBL3466709 0.72 SMN1; SMN2 (0.37) LMNASMN1; SMN2HPGDALDH1A1KMT2A
SCHEMBL3466707 0.72 SMN1; SMN2 (0.37) LMNASMN1; SMN2HPGDALDH1A1KMT2A
SCHEMBL9733978 0.71 MAPT (0.47) LMNASMN1; SMN2HPGDALOX12ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100273651-A1 Azolylmethyloxiranes, use Thereof and Agents Containing the Same BASF SE (DE) 2010-10-28 US disclosed
EP-2235005-A2 AZOLYLMETHYLOXIRANES, USE THEREOF AND AGENTS CONTAINING THE SAME BASF SE (DE) 2010-10-06 EP disclosed
WO-2009077500-A2 AZOLYLMETHYLOXIRANES, USE THEREOF AND AGENTS CONTAINING THE SAME BASF SE (DE) 2009-06-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100273651-A1 Azolylmethyloxiranes, use Thereof and Agents Containing the Same XDH, SQOR, NOX5 LMNA 4264/4885SMN1; SMN2 2481/4885HPGD 185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.